Market Research Life Sciences Market Research Pharmaceuticals Market Research Clinical Trial Market Research

Global Clinical Trial Supplies Market Databank

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 85 Pages Magna Intelligence April, 2022 MAIN17856283
Best Price Guarantee
Price from $1,500
Length 85 Pages
Publisher Magna Intelligence
Published Date April, 2022
SKU MAIN17856283

Global Clinical Trial Supplies Market Databank

The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device segment is anticipated to reach $959.0 Million by 2029 with the highest CAGR of 7.58%. Pharmaceutical and Medical device segments collectively expected to account for about 70.4% share of the Clinical Trial Supplies market in 2020, with the former constituting around 46.5% share. Medical device and Biologics segments are expected to witness significant growth rates at a CAGR of 7.58% and 7.53% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 38.4% in the overall Clinical Trial Supplies market in 2020, and is anticipated to reach 38.6% by 2029.


1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY END USE
1.1. OVERVIEW
1.2. PHARMACEUTICAL
1.2.1 PHARMACEUTICAL MARKET, BY REGION
1.2.1.1 North America Pharmaceutical Market, By Country
1.2.1.2 Europe Pharmaceutical Market, By Country
1.2.1.3 Asia-Pacific Pharmaceutical Market, By Country
1.2.1.4 Rest of World Pharmaceutical Market, By Country
1.3. BIOLOGICS
1.3.1 BIOLOGICS MARKET, BY REGION
1.3.1.1 North America Biologics Market, By Country
1.3.1.2 Europe Biologics Market, By Country
1.3.1.3 Asia-Pacific Biologics Market, By Country
1.3.1.4 Rest of World Biologics Market, By Country
1.4. MEDICAL DEVICE
1.4.1 MEDICAL DEVICE MARKET, BY REGION
1.4.1.1 North America Medical device Market, By Country
1.4.1.2 Europe Medical device Market, By Country
1.4.1.3 Asia-Pacific Medical device Market, By Country
1.4.1.4 Rest of World Medical device Market, By Country
1.5. OTHER END USES
1.5.1 OTHER END USES MARKET, BY REGION
1.5.1.1 North America Other End uses Market, By Country
1.5.1.2 Europe Other End uses Market, By Country
1.5.1.3 Asia-Pacific Other End uses Market, By Country
1.5.1.4 Rest of World Other End uses Market, By Country
2. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
2.1. OVERVIEW
2.2. PHASE I
2.2.1 PHASE I MARKET, BY REGION
2.2.1.1 North America Phase I Market, By Country
2.2.1.2 Europe Phase I Market, By Country
2.2.1.3 Asia-Pacific Phase I Market, By Country
2.2.1.4 Rest of World Phase I Market, By Country
2.3. PHASE II
2.3.1 PHASE II MARKET, BY REGION
2.3.1.1 North America Phase II Market, By Country
2.3.1.2 Europe Phase II Market, By Country
2.3.1.3 Asia-Pacific Phase II Market, By Country
2.3.1.4 Rest of World Phase II Market, By Country
2.4. PHASE III
2.4.1 PHASE III MARKET, BY REGION
2.4.1.1 North America Phase III Market, By Country
2.4.1.2 Europe Phase III Market, By Country
2.4.1.3 Asia-Pacific Phase III Market, By Country
2.4.1.4 Rest of World Phase III Market, By Country
2.5. OTHER CLINICAL PHASES
2.5.1 OTHER CLINICAL PHASES MARKET, BY REGION
2.5.1.1 North America Other Clinical Phases Market, By Country
2.5.1.2 Europe Other Clinical Phases Market, By Country
2.5.1.3 Asia-Pacific Other Clinical Phases Market, By Country
2.5.1.4 Rest of World Other Clinical Phases Market, By Country
3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY REGION
3.1. OVERVIEW
3.2. NORTH AMERICA
3.2.1 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USE
3.2.2 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
3.2.3 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY
3.2.3.1 U.S.
3.2.3.1.1 U.S. Clinical Trial Supplies Market, By End use
3.2.3.1.2 U.S. Clinical Trial Supplies Market, By Clinical Phase
3.2.3.2 Canada
3.2.3.2.1 Canada Clinical Trial Supplies Market, By End use
3.2.3.2.2 Canada Clinical Trial Supplies Market, By Clinical Phase
3.2.3.3 Mexico
3.2.3.3.1 Mexico Clinical Trial Supplies Market, By End use
3.2.3.3.2 Mexico Clinical Trial Supplies Market, By Clinical Phase
3.3. EUROPE
3.3.1 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY END USE
3.3.2 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
3.3.3 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY
3.3.3.1 Germany
3.3.3.1.1 Germany Clinical Trial Supplies Market, By End use
3.3.3.1.2 Germany Clinical Trial Supplies Market, By Clinical Phase
3.3.3.2 France
3.3.3.2.1 France Clinical Trial Supplies Market, By End use
3.3.3.2.2 France Clinical Trial Supplies Market, By Clinical Phase
3.3.3.3 UK
3.3.3.3.1 UK Clinical Trial Supplies Market, By End use
3.3.3.3.2 UK Clinical Trial Supplies Market, By Clinical Phase
3.3.3.4 Italy
3.3.3.4.1 Italy Clinical Trial Supplies Market, By End use
3.3.3.4.2 Italy Clinical Trial Supplies Market, By Clinical Phase
3.3.3.5 Spain
3.3.3.5.1 Spain Clinical Trial Supplies Market, By End use
3.3.3.5.2 Spain Clinical Trial Supplies Market, By Clinical Phase
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Clinical Trial Supplies Market, By End use
3.3.3.6.2
3.4. ASIA-PACIFIC
3.4.1 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USE
3.4.2 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
3.4.3 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY
3.4.3.1 China
3.4.3.1.1 China Clinical Trial Supplies Market, By End use
3.4.3.1.2 China Clinical Trial Supplies Market, By Clinical Phase
3.4.3.2 India
3.4.3.2.1 India Clinical Trial Supplies Market, By End use
3.4.3.2.2 India Clinical Trial Supplies Market, By Clinical Phase
3.4.3.3 Japan
3.4.3.3.1 Japan Clinical Trial Supplies Market, By End use
3.4.3.3.2 Japan Clinical Trial Supplies Market, By Clinical Phase
3.4.3.4 Australia
3.4.3.4.1 Australia Clinical Trial Supplies Market, By End use
3.4.3.4.2 Australia Clinical Trial Supplies Market, By Clinical Phase
3.4.3.5 South Korea
3.4.3.5.1 South Korea Clinical Trial Supplies Market, By End use
3.4.3.5.2 South Korea Clinical Trial Supplies Market, By Clinical Phase
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Clinical Trial Supplies Market, By End use
3.4.3.6.2 Rest of Asia Clinical Trial Supplies Market, By Clinical Phase
3.5. REST OF WORLD
3.5.1 REST OF WORLD CLINICAL TRIAL SUPPLIES MARKET, BY END USE
3.5.2 REST OF WORLD CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
3.5.3 REST OF WORLD CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY
3.5.3.1 Brazil
3.5.3.1.1 Brazil Clinical Trial Supplies Market, By End use
3.5.3.1.2 Brazil Clinical Trial Supplies Market, By Clinical Phase
3.5.3.2 South Africa
3.5.3.2.1 South Africa Clinical Trial Supplies Market, By End use
3.5.3.2.2 South Africa Clinical Trial Supplies Market, By Clinical Phase
3.5.3.3 GCC
3.5.3.3.1 GCC Clinical Trial Supplies Market, By End use
3.5.3.3.2 GCC Clinical Trial Supplies Market, By Clinical Phase
3.5.3.4 RoW Countries
3.5.3.4.1 RoW Countries Clinical Trial Supplies Market, By End use
3.5.3.4.2 RoW Countries Clinical Trial Supplies Market, By Clinical Phase

$1,500
$2,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings